Ausgabe 4/2019
Inhalt (17 Artikel)
The Current Landscape of Systemic Therapies for Advanced Hepatocellular Carcinoma
Prachi Rana, John Haydek, Anjana Pillai
Harms of Hepatocellular Carcinoma Surveillance
Jan Petrasek, Amit G. Singal, Nicole E. Rich
Liquid Biopsy for Hepatocellular Carcinoma
Vincent L. Chen, Neehar D. Parikh
Downstaging and Expanded Criteria Hepatocellular Carcinoma Liver Transplantation
Phillipe Abreu, Andre Gorgen, Christopher Griffiths, Tommy Ivanics, Gonzalo Sapisochin
Screening Indications and Treatments for Cholangiocarcinoma
Joseph C. Ahn, Ju Dong Yang
Spectrum of Drug Induced Liver Injury Caused by Anabolic Androgenic Steroids Abuse
Varun Takyar, Andrew Stolz
NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic Opportunities
Liyun Yuan, Ani Kardashian, Monika Sarkar
Should We Screen High-Risk Populations for NAFLD?
Cyrielle Caussy
Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease
Albert Do, Ysabel C. Ilagan-Ying, Wajahat Z. Mehal
Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease
Omar T. Ahmed, Alina M. Allen
NAFLD Histology: a Critical Review and Comparison of Scoring Systems
Rish K. Pai
HIV-Associated NAFLD: Disease Burden and Management
Alyson Kaplan, Jennifer C. Price
Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance
Kee-Huat Chuah, Wah-Kheong Chan
Future Therapies for Functional Cure of Chronic HBV: Review of Investigational Drugs in Phase 1 and 2 Development
Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Evidence-Based Approach to Stopping Oral Antiviral Therapy in Chronic HBV
Maximilian Wübbolding, Markus Cornberg, Christoph Höner zu Siederdissen
Update in Drug Development for Chronic HBV/HDV Infection
Dulce Alfaiate, Francesco Negro
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Byung-Han Rhieu, Amol K. Narang, Jeffrey Meyer